Fig. 4From: Expression levels of long non-coding RNAs are prognostic for AML outcomeLncRNA expression subtypes and overall survival (OS). a OS (Kaplan-Meier) in the full Clinseq-AML cohort (p value = 0.04, log-rank test). b OS (Kaplan-Meier) in cytogenetically normal patients in the Clinseq-AML cohort (p value = 0.02, log-rank test). c OS (Kaplan-Meier) in the TCGA-AML cohort (p value = 0.01, log-rank test). d OS (Kaplan-Meier) in cytogenetically normal patients in the TCGA-AML cohort (p value = 0.2, log-rank test)Back to article page